Today

Agents

Chat

Arena

Discover

More

App

Larimar Therapeutics Q2 Net Income USD -32.782 Million - LRMR News | Rallies

Larimar Therapeutics Q2 Net Income USD -32.782 Million

LRMR•2026-08-04

Second-quarter results

Aug. 4 (Reuters) - Larimar Therapeutics Q2 operating expenses USD 34.351 million.

Q2 income from operations USD -34.351 million
Q2 EPS USD -0.3

Related News

Global Business Travel Group FY26 Q2 net income rises 14% to $17 million; revenue increases 38% to $870 million

GBTG•2026-08-04

Iran demands inbound control of Hormuz and outbound oversight, source says

XLE•2026-08-04

Lisata Therapeutics falls after merger collapse prompts deep job cuts

LSTA

•

2026-08-04

Forex-Yen slips but holds intervention gains, traders alert to more action

UUP•2026-08-04

Barclays releases transcript of Q2 2026 sell-side analyst meeting

BCS•2026-08-04